KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Senseonics Holdings (SENS) Asset Writedowns and Impairment (2017 - 2025)

Senseonics Holdings (SENS) has disclosed Asset Writedowns and Impairment for 8 consecutive years, with $494000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment rose 112.4% to $494000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $694000.0, a 215.45% increase, with the full-year FY2025 number at $694000.0, up 215.45% from a year prior.
  • Asset Writedowns and Impairment was $494000.0 for Q4 2025 at Senseonics Holdings, up from $53000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $4.2 million in Q3 2024 to a low of -$4.0 million in Q4 2024.
  • A 4-year average of $107066.7 and a median of $85000.0 in 2023 define the central range for Asset Writedowns and Impairment.
  • Biggest YoY gain for Asset Writedowns and Impairment was 2595.45% in 2024; the steepest drop was 4785.88% in 2024.
  • Senseonics Holdings' Asset Writedowns and Impairment stood at -$1.1 million in 2021, then soared by 107.51% to $85000.0 in 2023, then plummeted by 4785.88% to -$4.0 million in 2024, then surged by 112.4% to $494000.0 in 2025.
  • Per Business Quant, the three most recent readings for SENS's Asset Writedowns and Impairment are $494000.0 (Q4 2025), $53000.0 (Q2 2025), and $147000.0 (Q1 2025).